Occasional Digest

Eli Lilly’s Olumiant receives expanded alopecia indication for children 12 and up (LLY:NYSE)

Finance Desk

Trichologist examines condition of teenage boyhair

Nadzeya Haroshka/iStock via Getty Images

  • The US FDA expanded the use of Eli Lilly’s (LLY) Olumiant (baricitinib) for severe alopecia areata to include children 12 years and older.
  • Approval was based on 36-week data from the adolescent cohort of the phase 3 BRAVE-AA-PEDS study that

Source link

Exit mobile version